GEODE CAPITAL MANAGEMENT, LLC - ENDOLOGIX INC ownership

ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 6 filers reported holding ENDOLOGIX INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ENDOLOGIX INC
ValueSharesWeighting
Q4 2018$1,514,000
-8.0%
2,118,562
+145.8%
0.00%
Q3 2018$1,645,000
-63.8%
861,930
+7.4%
0.00%
-100.0%
Q2 2018$4,543,000
+46.7%
802,761
+9.6%
0.00%0.0%
Q1 2018$3,097,000
-19.7%
732,173
+1.5%
0.00%0.0%
Q4 2017$3,859,000
+24.2%
721,491
+3.5%
0.00%0.0%
Q3 2017$3,107,000
-6.8%
696,788
+1.6%
0.00%0.0%
Q2 2017$3,332,000
-29.0%
685,661
+5.8%
0.00%
-50.0%
Q1 2017$4,693,000
+31.2%
648,288
+3.7%
0.00%0.0%
Q4 2016$3,576,000
-51.4%
625,267
+8.7%
0.00%
-50.0%
Q3 2016$7,361,000
+16.9%
575,097
+13.8%
0.00%
+33.3%
Q2 2016$6,297,000
+55.9%
505,393
+4.6%
0.00%
+50.0%
Q1 2016$4,039,000
-7.1%
483,205
+10.1%
0.00%0.0%
Q4 2015$4,346,000
-18.0%
439,018
+1.5%
0.00%
-33.3%
Q3 2015$5,302,000
-19.2%
432,469
+1.1%
0.00%
-25.0%
Q2 2015$6,562,000
-5.2%
427,799
+5.5%
0.00%0.0%
Q1 2015$6,923,000
+20.2%
405,614
+7.6%
0.00%
+33.3%
Q4 2014$5,761,000
+56.7%
376,816
+8.6%
0.00%
+50.0%
Q3 2014$3,676,000
-29.4%
346,840
+1.3%
0.00%
-33.3%
Q2 2014$5,208,000
+19.0%
342,452
+0.7%
0.00%0.0%
Q1 2014$4,375,000
-23.8%
339,999
+3.2%
0.00%
-25.0%
Q4 2013$5,744,000
+26.2%
329,374
+16.7%
0.00%0.0%
Q3 2013$4,553,000
+37.3%
282,280
+13.0%
0.00%
+33.3%
Q2 2013$3,316,000249,7110.00%
Other shareholders
ENDOLOGIX INC shareholders Q1 2019
NameSharesValueWeighting ↓
Tamarack Capital Management, LLC 4,050,000$49,653,0005.91%
Essex Woodlands Management, Inc. 1,257,468$21,220,0003.88%
PURA VIDA INVESTMENTS, LLC 205,100$2,515,0001.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,347,113$28,776,0001.11%
First Light Asset Management, LLC 180,963$2,219,0001.10%
ArrowMark Colorado Holdings LLC 2,889,546$35,426,0000.97%
PALISADE CAPITAL MANAGEMENT, LP 2,149,949$26,358,0000.78%
Iguana Healthcare Management, LLC 150,000$1,839,0000.72%
CADIAN CAPITAL MANAGEMENT, LP 1,492,443$18,297,0000.66%
WASHINGTON CAPITAL MANAGEMENT, INC 85,882$1,053,0000.66%
View complete list of ENDOLOGIX INC shareholders